-
With clearance from the Food and Drug Administration in hand, the German company licensed to market the Caya contoured diaphragm is seeking distribution and marketing partners to introduce the device in the United States.
-
The need for new contraception options is clear. In the United States, about half of the some 3.4 million pregnancies each year are unintended.
-
In the wake of the 2014 midterm elections, Congress has shifted decidedly to the political right. When the 114th Congress convenes in January 2015, Republicans will have their largest majority in the House of Representatives since World War II and will control the Senate for the first time since 2007.
-
“Providing Quality Family Planning Services — Recommendations of CDC and the U.S. Office of Population Affairs” is the newest member in the “suite” of family planning recommendations from the Centers for Disease Control and Prevention.
-
In a systematic review and meta-analysis of prospective studies examining the association between mental stress-induced myocardial ischemia (MSIMI) and adverse outcome events in patients with stable CAD, all existing investigations point to an approximate doubling of cardiovascular risk in patients with MSIMI.
-
-
The first in a new class of orexin receptor antagonists has been approved by the FDA for the treatment of insomnia. Orexins are hypothalamic neuropeptides that appear to have a role in maintaining wakefulness.
-
The American College of Physicians recommends against performing screening pelvic examination in asymptomatic, nonpregnant, adult women.
-
-
Detecting HIV early creates opportunity for treatment and reduces transmission risk.
